The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2017 / Feb / An Intense Focus on Perfusion
Manufacture Bioprocessing Biopharma Small Molecules Sponsored

An Intense Focus on Perfusion

Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion. Perfusion offers many benefits to bioprocessing, but choosing the right system and the right medium are key.Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion. Perfusion offers many benefits to bioprocessing, but choosing the right system and the right medium are key.

02/23/2017 1 min read

Share

Perfusion systems differ from their fed-batch counterparts in that they permit bioreactors to run continuously over extended periods of time by constantly perfusing fresh medium through the culture, simultaneously providing fresh nutrients for the cells and removing waste products. The key advantages of perfusion technology include higher yields per volume, increased flexibility, more consistent product quality and lower capital investment. Furthermore,  perfusion systems can be tweaked to support very high cell densities – this “intensified perfusion” can provide even higher product yields. Here, Delia Lyons, Senior Scientist, at MilliporeSigma, describes the benefits of perfusion in modern bioprocessing.

Figure 1. Volumetric production with three cell lines in benchmark fed-batch system compared to perfusion.

For more information about perfusion, please contact delia.lyons@sial.com

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics
Biopharma Biopharma
Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics

August 31, 2026

4 min read

New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products

The Hidden Complexity of Stability Storage
Biopharma Technology & Manufacturing
The Hidden Complexity of Stability Storage

August 27, 2026

9 min read

Why preserving samples is a scientific, regulatory, and operational challenge – and what’s at risk when it goes wrong

Green Shoots, Gray Skies
Biopharma Interviews Business & Trends
Green Shoots, Gray Skies

August 26, 2026

9 min read

Jon Rees sees signs of recovery following biotech's post-pandemic funding reset, but there’s no going back to the “old normal”

Phase III Success Marks Milestone for Personalized Cancer Vaccines
Biopharma Industry News Development & Clinical
Phase III Success Marks Milestone for Personalized Cancer Vaccines

August 26, 2026

7 min read

Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: